Skip to content

rESWT in the treatment of erectile dysfunction, urinary incontinence and penile EFD after prostatectomy

Research on rESWT treatment for erectile dysfunction, urinary incontinence, and penile EFD measurement after prostatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083574
Enrollment
Unknown
Registered
2024-04-28
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After prostatectomy

Interventions

The rESWT group:rESWT group: 1.5bar on the penis (1.8bar on the foot of the penis), 10hz, 300 shocks on each site, 3 sites on the left and right sides of the penis and the foot of the penis, twice a w
control group:Tadalafil at a dose of 5mg/day for 2 months

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Inclusion of 40-80 years old; ? Postoperative IIEF-5 8nmol/L, prolactin (PRL) =735mIU/L; ? Patients with non-self-occupied urine leakage after surgery, and 24-hour pad test positive patients; ? Meet the diagnostic criteria of stress urinary incontinence (SUI), that is, cough, laughter, sneezing and exercise when the abdominal pressure increases urine involuntary outflow.

Exclusion criteria

Exclusion criteria: ? Patients receiving pelvic radiotherapy or androgen deprivation therapy; ? Patients with uncontrolled mental state (depression); ? Postoperative Clavien-Dindo classification (CD > III); ? Endocrine diseases (such as hypogonadism or uncontrolled diabetes); ? Patients with urinary incontinence before surgery; ? Patients with neurogenic bladder, urethral stricture and other diseases; ? Take anticoagulant drugs or have coagulation dysfunction patients ? Patients who did not complete the follow-up.

Design outcomes

Primary

MeasureTime frame
International Index of Erectile Function short form-5;Erectile hardness scale;Rigisca;Summary of the International Commission on Urinary Incontinence Consultation Urinary Incontinence Questionnaire;

Secondary

MeasureTime frame
Overall evaluation questionnaire 1;Quality of life rating;Sexual Diary Question 2;Sexual Diary Question 3;Overall Evaluation Questionnaire 2;

Countries

China

Contacts

Public ContactJin Xiaodong

Zhejiang Provincial Hospital of Traditional Chinese Medicine

kingshoulder@163.com+86 137 5719 1398

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026